Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24

Vaccine

Volumn 20, Issue 11-12, 2002, Pages 1631-1639

  Moraes, M P ^a   Mayr, G A ^a   Mason, P W ^a   Grubman, M J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Adenovirus; Foot and mouth disease; Swine; Vaccine

Indexed keywords

CAPSID PROTEIN; FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FOOT AND MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS 5; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VACCINATION; VIRUS STRAIN;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; DEFECTIVE VIRUSES; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; HUMANS; NEUTRALIZATION TESTS; SWINE; SWINE DISEASES; VACCINES, DNA; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0037154790     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00483-2     Document Type: Article

References (39)

1. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge
2. Foot-and-mouth disease
3. Foot-and-mouth disease outbreak
4. Aerobiology of FMD: An outline and recent advances
5. Strategic decisions to evaluate before implementing a vaccine programme in the face of a foot-and-mouth disease (FMD) outbreak
6. Developments in foot-and-mouth disease vaccines
7. Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK
8. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate
9. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: Difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus
10. Cloned viral protein vaccine for foot-and-mouth disease: Responses in cattle and swine
11. Using genetically engineered bacteria for vaccine production
12. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle
13. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence
14. Protection of cattle against foot-and-mouth disease by a synthetic peptide
15. New approaches to vaccination against foot-and-mouth disease
16. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants
17. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus
18. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine
19. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins
20. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection
21. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate
22. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs
23. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins
24. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus
25. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs
26. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: Induction of a neutralizing antibody response in guinea pigs
27. A simplified system for generating recombinant adenoviruses
28. pAd5-Blue: Direct ligation system for engineering recombinant adenovirus constructs
29. Manipulation of adenovirus vectors
30. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle
31. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway
32. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus
33. Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus-induced Ig subclass shifts
34. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot-and-mouth disease
35. Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations
36. Foot-and-mouth disease virus particles contain replicase protein 3D
37. Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LPBE) with a bioengineered 3D protein
38. Blocking ELISAs using the FMDV non-structural proteins 3D, 3AB, and 3ABC produced in the baculovirus expression system